Biophysical aspects of Auger processes

Acta Oncologica

Volumn 39, Issue 6, 2000, Pages 651-657

  Hofer, K G ^a  

^a FLORIDA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IDOXURIDINE; IODINE 125; RADIOISOTOPE; RADIOPROTECTIVE AGENT;

AUGER ELECTRON SPECTROSCOPY; CANCER; CANCER THERAPY; CELL DAMAGE; CHO CELL; CONFERENCE PAPER; DNA STRAND BREAKAGE; ELECTRON THERAPY; GENOME; HUMAN; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RADIOISOTOPE DECAY; TUMOR CELL CULTURE;

BIOPHYSICS; BRACHYTHERAPY; DNA DAMAGE; DNA, NEOPLASM; ELECTRONS; HUMANS; NEOPLASMS;

EID: 0033710914     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418600750063686     Document Type: Conference Paper

References (80)

1. Sur les rayons β secondaires produit dans un gaz des rayons X
2. 125I: A review: Report No. 1 of AAPM Nuclear Medicine Task Group No. 6
3. 125I
4. 125I-iododeoxyuridine
5. Radiotoxicity of intranuclear tritium, iodine-125, and iodine-131
6. Biological toxicity associated with the Auger effect
7. Iodine-125, a tracer in cell biology: Physical properties and biological aspects
8. 125I in cell DNA at - 196 degrees C
9. The radiotoxicity of mammalian cells. I. Effects on the survival curve of radioiodine incorporated into DNA
10. 4
11. + and recA strains of Escherichia coli
12. Biological toxicity of Auger emitters: Molecular fragmentation vs. electron irradiation
13. 125I
14. 3H: Nuclear versus cytoplasmic radiation effects in murine L1210 leukemia
15. Radionuclide toxicity in cultured mammalian cells: Elucidation of the primary target of radiation damage
16. Radiotoxicity of Se-75 and S-35: Theory and application to a cellular model
17. 125I incorporated into mammalian DNA
18. 125I]iodo-2'-deoxyuridine incorporated into DNA of mammalian cells, and their RBEs
19. Quantitative studies of cytotoxicity, mutagenesis and oncologic transformation by radioisotopes incorporated into DNA
20. 3H-TdR
21. 125I incorporated into DNA of Chinese hamster cells
22. Radionuclide toxicity in cultured mammalian cells: Elucidation of the primary site for radiation-induced mitotic delay
23. The target for radiation-induced division delay
24. Range of radiochemical damage to DNA with decay of iodine-125
25. Strand breaks in plasmid DNA following positional changes of Auger-emitting radionuclides
26. Comparison of strand breaks in plasmid DNA after positional changes of Auger electron-emitting iodine-125
27. Strand breaks after the decay of iodine-125 in proximity to plasmid pBR322 DNA
28. Strand breaks in plasmid DNA following positional changes of Auger-electron-emitting iodine-125: Direct versus indirect effects
29. Indirect mechanisms contribute to biological effects produced by decay of DNA-incorporated iodine-125 in mammalian cells in vitro: Double-strand breaks
30. Sequence-specific DNA breaks produced by triplex-directed decay of iodine-125
31. 125I incorporated into a triplex-forming oligonucleotide correlates with geometry of the triplex
32. 125I-labeled oligonucleotides
33. Cellular and subcellular studies of the radiation effects of Auger electron-emitting estrogens
34. DNA and chromosome breaks induced by iodine-123-labeled estrogen in Chinese hamster ovary cells
35. 125I-estrogen
36. 125I
37. A new DNA target model for track structure calculations and its first application to I-125 Auger electrons
38. Modelling of radiation-induced DNA damage: The early physical and chemical events
39. Modelling of radiation-induced DNA damage: The early physical and chemical events
40. 125I on a nucleosome
41. Low-energy electrons inside active DNA models: A tool to elucidate the radiation action mechanisms
42. 123I and carbon
43. Biological effectiveness of 67-gallium in HL60 cells compared with external low dose rate gamma irradiation: Effects on proliferation, G2 arrest, and clonogenic capacity
44. Radiotoxicity of some iodine-123, iodine-125, and iodine-131-labeled compounds in mouse testes: Implications for radiopharmaceutical design
45. 125I decay
46. 125IUdR cytotoxicity
47. Radiotoxicity of an I-125-labeled DNA intercalator in mammalian cells
48. The radiation dose to cells in vitro from intracellular indium-111
49. Cytotoxicity of some indium radiopharmaceuticals in mouse testes
50. Radiotoxicity of iodine-125-labeled oligodeoxyribonucleotides in mammalian cells
51. Induction of spermhead abnormalities by incorporated radionuclides: Dependence on subcellular distribution, type of radiation, dose rate and presence of radioprotectors
52. Vitamins as radioprotectors in vivo: I. Protection by vitamin C against internal radionuclides in mouse testes: Implications to the mechanism of the Auger effect
53. Radioprotection against biological effects of internal radionuclides in vivo by S-(2-aminoethyl)isothioronium bromide hydrobromide (AET)
54. Vitamins as radioprotectors in vivo. II. Protection by vitamin A and soybean oil against radiation damage caused by internal radionuclides
55. Indirect mechanisms contribute to biological effects produced by decay of DNA-incorporated iodine-125 in mammalian cells in vitro: Clonogenic survival
56. Protection by DMSO against cell death caused by intracellularly localized iodine-125, iodine-131, and polonium-210
57. Biophysical models of mammalian cell inactivation by radiation
58. 125I decay
59. High LET and low LET cytocidal effects of DNA-associated iodine-125
60. 125I decays in DNA: Effect of cysteamine on micronucleus formation and cell death
61. 125I decays in DNA
62. Biological damage from the Auger effect, possible benefits
63. 125I damage in mammalian cells
64. Radioimmunotherapy dosimetry - A review
65. Dosimetry of Auger-electron emitting radionuclides: Report No. 3 of the AAPM Nuclear Medicine Task Group No. 6
66. The spatial accuracy of cellular dose estimates obtained from 3D reconstructed tissue autoradiographs
67. Macroscopic dosimetry for radioimmunotherapy: Nonuniform activity distributions in solid tumors
68. Biophysical aspects of Auger processes: A review
69. Targeting radiation to tumours
70. 131I-labeled CO17-1A in a human colorectal cancer model
71. 125I]iodo-estradiol in cultured MCF-7 human breast cancer cells
72. Estrogen receptor-directed radiotoxicity with Auger electrons: Specificity and mean lethal dose
73. Radiotoxicity of Auger electron-emitting estrogens in MCF-7 spheroids: A potential treatment for estrogen receptor-positive tumors
74. Clinical pharmacology of 5-iodo-2'-deoxyuridine and 5-iodouracil and endogenous pyrimidine modulation
75. 125I]Iodo-2'-deoxyuridine in the radiotherapy of brain tumors in rats
76. Tumor-targeting potential of radioiodinated iododeoxyuridine in bladder cancer
77. 125I]iodo-2'-deoxyuridine in a rat model of leptomeningeal metastases
78. 123I]iodo-2'-deoxyuridine in patients with liver metastases from colorectal cancer
79. 123I]iodo-2'-deoxyuridine in a patient with brain tumor
80. Cell cycle-based purging of lymphoma cells from bone marrow harvests using radioiodinated 5-iodo-2'-deoxyuridine